Beijing Konruns Pharmaceutical Co (SHSE:603590) Long-Term Debt : ¥40.4 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Long-Term Debt?

Beijing Konruns Pharmaceutical Co's Long-Term Debt for the quarter that ended in Mar. 2024 was ¥40.4 Mil.

Beijing Konruns Pharmaceutical Co's quarterly Long-Term Debt declined from Sep. 2023 (¥48.9 Mil) to Dec. 2023 (¥43.8 Mil) and declined from Dec. 2023 (¥43.8 Mil) to Mar. 2024 (¥40.4 Mil).

Beijing Konruns Pharmaceutical Co's annual Long-Term Debt stayed the same from Dec. 2021 (¥0.0 Mil) to Dec. 2022 (¥0.0 Mil) but then increased from Dec. 2022 (¥0.0 Mil) to Dec. 2023 (¥43.8 Mil).

Beijing Konruns Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Long-Term Debt Chart

Beijing Konruns Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

43.78

Beijing Konruns Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															50.52	50.59	48.90	43.78	40.42

Beijing Konruns Pharmaceutical Co (SHSE:603590) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Beijing Konruns Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN

Website

http://www.konruns.cn

Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Executives

Feng Zhang Zheng

Director

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines